Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin M Larimer

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2018
The Effectiveness of Checkpoint Inhibitor Combinations and Administration Timing Can Be Measured by Granzyme B PET ImagingBenjamin M Larimer, Emily Bloch, Sarah Nesti, et al.
Pharmaceutics|February 26, 2025
PET Imaging of CD206 Macrophages in Bleomycin-Induced Lung Injury Mouse ModelVolkan Tekin, Yujun Zhang, Clayton Yates, et al.
Cancer Research|May 3, 2017
Granzyme B PET Imaging as a Predictive Biomarker of Immunotherapy ResponseBenjamin M Larimer, Eric Wehrenberg-Klee, Frank Dubois, et al.
Nuclear Medicine and Biology|May 21, 2024
[<sup>18</sup>F]FMISO-PET imaging reveals the role of hypoxia severity in checkpoint blockade responseKaytlyn C McNeal, Kirsten M Reeves, Patrick N Song, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 2, 2018
Specific <sup>18</sup>F-FDHT Accumulation in Human Prostate Cancer Xenograft Murine Models Is Facilitated by Prebinding to Sex Hormone-Binding GlobulinBenjamin M Larimer, Frank Dubois, Emily Bloch, et al.
Protein Engineering, Design & Selection : PEDS|February 17, 2022
Comprehensive mapping of SARS-CoV-2 peptide epitopes for development of a highly sensitive serological test for total and neutralizing antibodiesGarima Kumar, Sarah Sterrett, Lucinda Hall, et al.
Molecular Pharmaceutics|August 8, 2023
Evaluation of [<sup>89</sup>Zr]Zr-DFO-2Rs15d Nanobody for Imaging of HER2-Positive Breast CancerMaxwell Ducharme, Lucinda Hall, Whitney Eckenroad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2021
<sup>18</sup>F-FMISO PET Imaging Identifies Hypoxia and Immunosuppressive Tumor Microenvironments and Guides Targeted Evofosfamide Therapy in Tumors Refractory to PD-1 and CTLA-4 InhibitionKirsten M Reeves, Patrick N Song, Allyson Angermeier, et al.
Molecules (Basel, Switzerland)|April 3, 2021
[<sup>89</sup>Zr]-Pertuzumab PET Imaging Reveals Paclitaxel Treatment Efficacy Is Positively Correlated with HER2 Expression in Human Breast Cancer Xenograft Mouse ModelsYun Lu, Meng Li, Adriana V F Massicano, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 29, 2025
Granzyme B PET Imaging Predicts Response to Immunotherapy in a Diet-Induced Obesity Model of Breast CancerShannon E Lynch, Corinne Crawford, Addison L Hunt, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2018
The Effectiveness of Checkpoint Inhibitor Combinations and Administration Timing Can Be Measured by Granzyme B PET ImagingBenjamin M Larimer, Emily Bloch, Sarah Nesti, et al.
Pharmaceutics|February 26, 2025
PET Imaging of CD206 Macrophages in Bleomycin-Induced Lung Injury Mouse ModelVolkan Tekin, Yujun Zhang, Clayton Yates, et al.
Cancer Research|May 3, 2017
Granzyme B PET Imaging as a Predictive Biomarker of Immunotherapy ResponseBenjamin M Larimer, Eric Wehrenberg-Klee, Frank Dubois, et al.
Nuclear Medicine and Biology|May 21, 2024
[<sup>18</sup>F]FMISO-PET imaging reveals the role of hypoxia severity in checkpoint blockade responseKaytlyn C McNeal, Kirsten M Reeves, Patrick N Song, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 2, 2018
Specific <sup>18</sup>F-FDHT Accumulation in Human Prostate Cancer Xenograft Murine Models Is Facilitated by Prebinding to Sex Hormone-Binding GlobulinBenjamin M Larimer, Frank Dubois, Emily Bloch, et al.
Protein Engineering, Design & Selection : PEDS|February 17, 2022
Comprehensive mapping of SARS-CoV-2 peptide epitopes for development of a highly sensitive serological test for total and neutralizing antibodiesGarima Kumar, Sarah Sterrett, Lucinda Hall, et al.
Molecular Pharmaceutics|August 8, 2023
Evaluation of [<sup>89</sup>Zr]Zr-DFO-2Rs15d Nanobody for Imaging of HER2-Positive Breast CancerMaxwell Ducharme, Lucinda Hall, Whitney Eckenroad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2021
<sup>18</sup>F-FMISO PET Imaging Identifies Hypoxia and Immunosuppressive Tumor Microenvironments and Guides Targeted Evofosfamide Therapy in Tumors Refractory to PD-1 and CTLA-4 InhibitionKirsten M Reeves, Patrick N Song, Allyson Angermeier, et al.
Molecules (Basel, Switzerland)|April 3, 2021
[<sup>89</sup>Zr]-Pertuzumab PET Imaging Reveals Paclitaxel Treatment Efficacy Is Positively Correlated with HER2 Expression in Human Breast Cancer Xenograft Mouse ModelsYun Lu, Meng Li, Adriana V F Massicano, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 29, 2025
Granzyme B PET Imaging Predicts Response to Immunotherapy in a Diet-Induced Obesity Model of Breast CancerShannon E Lynch, Corinne Crawford, Addison L Hunt, et al.
Pageof 3